15.56
-0.19 (-1.21%)
| 前收盘价格 | 15.75 |
| 收盘价格 | 15.73 |
| 成交量 | 162,588 |
| 平均成交量 (3个月) | 575,537 |
| 市值 | 5,646,988,800 |
| 预期市盈率 (P/E Forward) | 13.42 |
| 价格/销量 (P/S) | 0.900 |
| 股市价格/股市净资产 (P/B) | 0.670 |
| 52周波幅 | |
| 利润日期 | 19 Feb 2025 |
| 营业毛利率 | -6.62% |
| 营业利益率 (TTM) | 6.72% |
| 稀释每股收益 (EPS TTM) | -0.900 |
| 季度收入增长率 (YOY) | 9.10% |
| 总债务/股东权益 (D/E MRQ) | 75.43% |
| 流动比率 (MRQ) | 1.60 |
| 营业现金流 (OCF TTM) | 232.00 M |
| 杠杆自由现金流 (LFCF TTM) | 188.38 M |
| 资产报酬率 (ROA TTM) | 0.96% |
| 股东权益报酬率 (ROE TTM) | -4.53% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看跌 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | Bausch + Lomb Corporation | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | -3.5 |
| 内部交易活动 | -3.0 |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | -1.60 |
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 88.18% |
| 机构持股比例 | 10.25% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Maple Rock Capital Partners Inc. | 31 Dec 2024 | 3,171,053 |
| Alberta Investment Management Corp | 31 Dec 2024 | 3,008,193 |
| Goldentree Asset Management Lp | 31 Dec 2024 | 1,732,197 |
| Whitebox Advisors Llc | 31 Dec 2024 | 1,443,101 |
| King Street Capital Management, L.P. | 31 Dec 2024 | 1,136,321 |
| Mangrove Partners Im, Llc | 31 Dec 2024 | 1,059,133 |
| Laurion Capital Management Lp | 31 Dec 2024 | 1,033,880 |
| Empyrean Capital Partners, Lp | 31 Dec 2024 | 931,000 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 17.00 (RBC Capital, 9.25%) | 购买 |
| 17.00 (B of A Securities, 9.25%) | 卖出 | |
| 中 | 15.00 (-3.60%) | |
| 低 | 12.00 (Morgan Stanley, -22.88%) | 保留 |
| 12.00 (Wells Fargo, -22.88%) | 保留 | |
| 平均值 | 14.56 (-6.43%) | |
| 总计 | 3 购买, 4 保留, 1 卖出 | |
| 平均价格@调整类型 | 12.35 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 06 May 2025 | 12.00 (-22.88%) | 保留 | 11.56 |
| HC Wainwright & Co. | 02 May 2025 | 15.00 (-3.60%) | 购买 | 11.56 |
| 21 Feb 2025 | 20.00 (28.53%) | 购买 | 15.75 | |
| Citigroup | 01 May 2025 | 13.00 (-16.45%) | 保留 | 11.56 |
| Evercore ISI Group | 01 May 2025 | 15.50 (-0.39%) | 购买 | 11.56 |
| Wells Fargo | 01 May 2025 | 12.00 (-22.88%) | 保留 | 11.56 |
| 28 Mar 2025 | 15.00 (-3.60%) | 保留 | 14.13 | |
| RBC Capital | 04 Apr 2025 | 17.00 (9.25%) | 购买 | 12.11 |
| 20 Feb 2025 | 18.00 (15.68%) | 购买 | 15.89 | |
| Stifel | 03 Apr 2025 | 15.00 (-3.60%) | 保留 | 12.99 |
| B of A Securities | 20 Feb 2025 | 17.00 (9.25%) | 卖出 | 15.89 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合